QuantRx Biomedical Corporation filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 USD | -.--% | -.--% | -49.37% |
1st Jan change | Capi. | |
---|---|---|
-49.37% | 315K | |
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 154B | |
+31.66% | 112B | |
+1.37% | 64.16B | |
+19.45% | 54.88B | |
-2.27% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B |
- Stock Market
- Equities
- QTXB Stock
- News QuantRx Biomedical Corporation
- QuantRx Biomedical Corporation Auditor Raises 'Going Concern' Doubt